BPC-157

Key points

• BPC-157 is a laboratory made chain of 15 amino acids, modelled on part of a protein found in the stomach.
• Most of what is known comes from animal and laboratory studies. Good quality human evidence is still very limited.
• In the UK it has no marketing authorisation, so it is not a licensed medicine and is sold only for research use.
• It is on the WADA Prohibited List, so it is not permitted in competitive sport.

Quick facts

What it is

Synthetic peptide, 15 amino acids

Studied for

Tissue repair: tendon, muscle, gut lining

UK status

Not a licensed medicine; sold for research use

Human evidence

Very limited; most data is from animals

In sport

On the WADA Prohibited List

How it works

In animal studies BPC-157 appears to support the body's own repair processes. Researchers have looked at effects on the growth of small blood vessels, on the cells that build tendon and ligament, and on signalling molecules such as nitric oxide. These are plausible pathways for healing, but they have mostly been shown in animals and in cell cultures, and have not been confirmed in large human trials.

What the evidence shows

The animal work is genuinely interesting, and consistent enough across different injury models that researchers keep studying it. The gap is in people. There are very few human studies, and none of the large controlled trials that would be needed to show a clear benefit or to license a medicine. So the fair summary is that BPC-157 looks promising in the laboratory and remains unproven in humans.

What it does not settle

• Whether the animal results carry across to people is not yet known.
• Long term safety in humans has not been studied.
• Products sold as BPC-157 are not checked for purity, dose or contamination, so what is in a vial can vary.

Side effects

Common

• In animal studies BPC-157 has generally been well tolerated, with few obvious adverse effects reported. That does not tell us how it behaves in people over time, which has not been properly studied.

Less common but serious

• Anyone with a history of cancer may wish to be cautious, since compounds that encourage new blood vessel growth are best avoided until more is known.
• Because material is bought from unregulated sellers, an unknown dose, contamination or a mislabelled product are real practical risks.

Report any suspected side effect through the MHRA Yellow Card scheme.

UK legal status and access

BPC-157 has no UK marketing authorisation, so it is not a licensed medicine and is not offered by registered clinics or pharmacies. It is usually sold online labelled for research use. A research label does not mean a product has been assessed for safety, quality or dose.

Common questions